arc-8: targeting cd73 inhibition in mpdac with quemliclustat and zimberelimab
Published 3 months ago • 48 plays • Length 5:23Download video MP4
Download video MP3
Similar videos
-
0:50
targeting pancreatic cancer with cd73 inhibition
-
21:19
endocrine resistance: mechanisms and treatment strategies
-
8:36
alnuctamab, a bcma x cd3 t-cell engager, in pts with relapsed/refractory multiple myeloma
-
5:54
proteomics in cancer detection
-
37:59
histidine-tagged protein capture using the proteon™ xpr36 system
-
8:39
tcr complex and cd4 cd8 proteins
-
26:36
t cell activation and control
-
2:35
kisima™ cancer vaccine (atp-128): mechanism of action
-
15:56
molecular tests for targeted therapies in advanced nsclc
-
5:32
esmo 2020 expert video report on cdk4 6i in the adjuvant treatment of breast cancer
-
1:26
impact of cd8 t cell activation in the presence of tlr agonists
-
2:04
acquired resistance to osimertinib in t790m-positive nsclc
-
17:18
case 14_colonoscopy with chromoendoscopy and hybrid esd technique for recurrent colonic adenoma
-
0:54
kcrd induction for ndmm: myeloma xi trial analysis by molecular risk
-
1:38
meet john einck, md: radiation oncologist
-
6:53
treatment sequencing in advanced ovarian cancer
-
4:27
molecular testing beyond egfr and alk in stage iv nsclc
-
4:43
nanoscale proteomic analysis of oncoproteins in hematopoietic cancers
-
5:45
pro5® mhc pentamers: for the detection of antigen specific cd8 t cells
-
1:21
introducing the cd8 immunopet minibody
-
7:23
utilizing molecular testing to guide treatment options in breast cancer
-
4:09
patient follow-up in advanced crc